Financial reports
10-Q
2015 Q3
Quarterly report
6 Feb 15
10-Q
2015 Q2
Quarterly report
31 Oct 14
10-Q
2015 Q1
Quarterly report
31 Jul 14
10-K
2014 FY
Annual report
9 Jun 14
10-Q
2014 Q3
Quarterly report
6 Feb 14
10-Q
2014 Q2
Quarterly report
7 Nov 13
10-Q
2014 Q1
Quarterly report
1 Aug 13
10-K
2013 FY
Annual report
23 Jul 13
10-K/A
2013 FY
Annual report (amended)
23 Jul 13
NT 10-K
Notice of late annual filing
14 Jun 13
Current reports
8-K
Completion of Acquisition or Disposition of Assets
31 Mar 15
8-K
March 2015 Creating a New Medical Device Company Positioned for Growth
10 Mar 15
8-K
Uroplasty to Host Investor Meeting at Corporate Headquarters
3 Mar 15
8-K
Other Events
27 Jan 15
8-K
Uroplasty Reports Record Revenue in Fiscal Third Quarter
22 Jan 15
8-K
Uroplasty and Vision-Sciences to Merge, Creating Medical Device Company Positioned for Growth
22 Dec 14
8-K
Departure of Directors or Certain Officers
24 Oct 14
8-K
Uroplasty Reports Record Fiscal Second Quarter Revenue
23 Oct 14
8-K
Healthcare Industry Leader Kenneth H. Paulus Joins Uroplasty’s Board of Directors
15 Oct 14
8-K
Departure of Directors or Certain Officers
3 Oct 14
Registration and prospectus
15-12B
Securities registration termination
17 Apr 15
25-NSE
Exchange delisting
31 Mar 15
POS AM
Prospectus update (post-effective amendment)
31 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 15
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 15
425
Business combination disclosure
10 Mar 15
Proxies
DEFA14A
Additional proxy soliciting materials
10 Mar 15
DEFM14A
Proxy related to merger
23 Feb 15
DEF 14A
Definitive proxy
22 Jul 14
PRE 14A
Preliminary proxy
8 Jul 14
DEFA14A
Additional proxy soliciting materials
19 Aug 13
DEF 14A
Definitive proxy
29 Jul 13
DEF 14A
Definitive proxy
27 Jul 12
DEF 14A
Definitive proxy
27 Jul 11
DEF 14A
Definitive proxy
27 Jul 10
DEF 14A
Definitive proxy
24 Jul 09
Other
EFFECT
Notice of effectiveness
15 Apr 15
EFFECT
Notice of effectiveness
2 Dec 14
SD
Conflict minerals disclosure
2 Jun 14
UPLOAD
Letter from SEC
4 Feb 13
CORRESP
Correspondence with SEC
31 Jan 13
UPLOAD
Letter from SEC
30 Jan 13
UPLOAD
Letter from SEC
3 Mar 11
UPLOAD
Letter from SEC
14 Feb 11
EFFECT
Notice of effectiveness
24 Jun 10
CORRESP
Correspondence with SEC
22 Jun 10